Professor of Medicine, Rush University Medical Center Associate Chief Medical Officer, Vice Chair and Division Chief
Internal Medicine
Dr. Amir K. Jaffer, MD
Dr. Amir K. Jaffer practices Internal Medicine. He went to medical school at Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine Dr. Amir K. Jaffer has written publications. He has 47 publications published with PubMed. The lastest paper is: 'Severe back and abdominal pain in a 44-year-old woman.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Perioperative cardiovascular medicine: an update of the literature 2013-2014.
- Education Research: Can my electronic health record teach me something?: A multi-institutional pilot study.
- Update in Perioperative Medicine 2011.
- Update in hospital medicine: studies likely to affect inpatient practice in 2011.
- Update in perioperative medicine.
- An academic center's delivery of care after the Haitian earthquake.
- Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
- Perioperative anticoagulant management.
- Perioperative management of warfarin and antiplatelet therapy.
- Perioperative medicine update.
- ACP Journal Club. Selective decontamination of the digestive tract and selective oropharyngeal decontamination reduced mortality in the ICU.
- Prevention of venous thromboembolism after surgery.
- Prevention of venous thromboembolism in hospitalized medical patients.
- Perioperative beta-blockers in noncardiac surgery: evolution of the evidence.
- Prevention of venous thromboembolism in the cancer surgery patient.
- Venous thromboembolism (VTE).
- Prevention of venous thromboembolism in the orthopedic surgery patient.
- Prevention of venous thromboembolism in the hospitalized medical patient.
- An overview of venous thromboembolism: impact, risks, and issues in prophylaxis.
- Outcomes of patients with stable heart failure undergoing elective noncardiac surgery.
- Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study.
- A new home awaits the hospitalist.
- When should prophylactic anticoagulation begin after a hip fracture?
- Anticoagulation management strategies for patients on warfarin who need surgery.
- Prevention of venous thromboembolism in the geriatric patient.
- Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty.
- Current and emerging options in the management of venous thromboembolism.
- Issues in anticoagulant therapy: recent trials start to answer the tough questions.
- Low-molecular-weight heparin or stockings for preventing coach class thrombosis?
- When patients on warfarin need surgery.
- Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care.
- The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
- Managing anticoagulant related coagulopathy.
- Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
- Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty.
- Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty.
- 'Coach class thrombosis': is the risk real? What do we tell our patients?
- Unrecognized sleep apnea in the surgical patient: implications for the perioperative setting.
- Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.
- Transforming invasive bedside procedural instruction.
- Practical tips for warfarin dosing and monitoring.
- A 46-year-old intravenous drug user with fever.
- Demystifying two common genetic predispositions to venous thrombosis.
- Severe back and abdominal pain in a 44-year-old woman.
- Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults.
- CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.
Schools
Boston University School Of Medicine
Yale New Haven Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Boston University School of Medicine
Hospital
-
Rush University Medical Center
Drug Facts
| NPI NUMBER | 1093779571 | |
| NPPES Provider LastName | JAFFER | |
| NPPES Provider FirstName | AMIR | |
| NPPES Provider ZIPCode | 331361003 | |
| NPPES Provider State | FL | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 22.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093779571 |
| Last Name Of The Provider | JAFFER |
| First Name Of The Provider | AMIR |
| View All |
Similar Doctors
|
Dr. Daisy Acevedo Morales, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maritza M. Suarez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gustavo A. De La Portilla, MD |
|
|
Dr. Ruben J. Ayala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leon W. Rawner, MD |
|
|
Dr. Martin P. Rothberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Lisa J. Welsh, PA-C
This Doctor is OpenDoctor Recommended.
|